期刊文献+

胃癌组织中淋巴管内皮生成因子受体3的表达及临床意义

下载PDF
导出
出处 《临床荟萃》 CAS 2009年第23期2061-2063,F0002,共4页 Clinical Focus
基金 湖北省卫生厅科研基金指导性项目(2006JX2C39)
  • 相关文献

参考文献14

  • 1Petrova TV, Makinen T, Alitalo K. Signaling via vascular endothelial growth factor receptors[J]. Exp Cell Res, 1999,253 (1):117-130.
  • 2Gerwins P, Skoldenberg E, Claesson-Welsh L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis[J]. Crit Rev Oncol Hematol,2000,34(3) :185-194.
  • 3Veikkola T,Alitalo K. VEGFs, receptors and angiogenesis[J]. Semin Cancer Biol,1999,9(3):211-220.
  • 4yon Marschall Z, Scholz A, Stacker SA, et al. Vascular endothelial growth factor-D induces iymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer[J]. Int J Oncol,2005,27(3):669-679.
  • 5Ohno M. Nakamura T, Kunimoto Y, et al. Lymphagenesis correlates with expression of vascular endothelial growth factor-C in colorectal cancer[J]. Oncol Rep, 2003,10 (4) : 939- 943.
  • 6Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases [J]. EMBO J,1996,15(7) :1751.
  • 7王玉珍,梁志清.血管内皮生长因子-C与恶性肿瘤的淋巴管生成及淋巴结转移关系研究进展[J].肿瘤防治杂志,2004,11(11):1217-1220. 被引量:8
  • 8Makinen T, Jussila L, Veikkola T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenie mice expression soluble VEGF reeeptor-3[J]. Nat Med,2001,7 (2) :199-205.
  • 9Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis[J]. Nat Med,2001,7(2) :192-198.
  • 10Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics[J]. Nat Med, 2001,7(2) : 186-191.

二级参考文献59

  • 1牟江洪,阎晓初,李增鹏,王东,段光杰,向德兵,肖华亮,张沁宏.结直肠癌淋巴管生成的特点及其临床病理意义[J].中华病理学杂志,2005,34(6):348-352. 被引量:39
  • 2Karkkainen MJ, Makinen T,Alitalo K. Lymphatic endothelium: a new frontier of metastasis research. Nature Cell Biol,2002, 4: E2-E5.
  • 3Saharinen P, Petrova TV. Molecular Regulation of Lymphangiogenesis. Ann NY Acad Sci,2004, 1014:76-87.
  • 4Clarijs R, Schalkwijk L, Hofmann UB, et al. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. Cancer Res,2002, 62:7059-7065.
  • 5Kriehuber E, Breiteneder SG, Groeger M, et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med, 2001, 194:797-808.
  • 6Carreira CM, Nasser SM, Tomaso E, et al. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res,2001, 61: 8079-8084.
  • 7Wigle JT, Harvey N, Detmar M, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBOJ,2002, 21:1505-1513.
  • 8Munoz-Guerra MF, Marazuela EG, Martin-Villar E, et al. Prognostic significance of intratumoral lymphangiogenesis in squamous cell carcinoma of the oral cavity. Cancer, 2004, 100:553-560.
  • 9Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science,1997, 276:1423-1425.
  • 10Shimizu K, Kubo H, Yamaguchi K,et al. Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci,2004, 95:328-333.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部